Back to Awarded Treatment Trials


Awarded Trial: 19T-002

Grant ID

19T-002

Illness

Schizophrenia

Primary Drug/Intervention

Acetazolamide

Primary Dosage

2G/day in divided doses

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Enrolling

Investigator

Vish Nimgaonkar

Sample Size

60

Duration of Study Period for Each Subject

24 weeks

Outcome Measurements

Clinical severity (PANSS 85), cognition (Trail Making Test), overall/social function (Sheehan's disability scale, Global Assessment of Function, Quality of Life Scale) and SE will be assessed.

Results

N/A

Publication

N/A

Link

N/A

PI Name

Vish Nimgaonkar

Degree

MD, PhD

Center

N/A

Institution

University of Pittsburgh

Address

3811 O'Hare Street, WPH #441

City or Town

Pittsburgh

State or Province

PA

Zip or Postal Code

15217

Country

USA

Email Address

nimga@pitt.edu